Sep 29, 20221 minGhada Maged receives NDR student awardNDR is pleased to announce research support for Ghada Maged for an ALS biomarkers project. Ms. Maged is currently completing an M. Sc....
Sep 22, 20221 minDr. Chandler Walker moves to final round of IU Idea to Startup Pitch CompetitionDr. Walkers business idea "Cell-based therapy for ALS" was selected for advancing to the IU Idea to Startup Pitch Competition finals....
Sep 16, 20221 minA Personal Message from Dr. SiddiqueIn this final installment, Dr. Siddique delivers a personal message.
Sep 12, 20221 minSecond Video InstallmentIn this second installment, Dr. Siddique discusses the future of ALS research and its implications for researchers and patients. We hope...
Sep 7, 20221 minNew Video SeriesWe're pleased to announce that Northwestern University-Feinberg School of Medicine has produced a three-part video series on ALS,...
Aug 31, 20221 minNDR's TVALA® TrademarkedThe lead molecule under development by NDR for treating neuroinflammation is the retro-inverso thymopentin, TVALA®. The application for...
Aug 17, 20221 minLow-cost detection of ALS biomarkersDr. Mohtashim Shamsi, Southern Illinois University, finalized his 2-year project with NDR. Shamsi investigated the feasibility of using...
Jun 29, 20224 minNDR White Paper Issue 21: Peptide Array Technology Provides a Cornerstone for ALS ResearchMicroarray technology using ALS-associated peptides